Business Context and Reporting Period
Company: Compass Diversified Holdings (Compass Diversified Trust and Compass Group Diversified Holdings LLC)
Reporting Period: Quarter and six months ended June 30, 2006
Context: This is the company's first quarterly report following its Initial Public Offering (IPO) and the acquisition of four "initial businesses" on May 16, 2006. The consolidated financial statements reflect operations for only 46 days (May 16 to June 30, 2006). The company operates as a holding company for small and middle-market businesses, including CBS Personnel (staffing), Crosman (recreational products), Advanced Circuits (PCBs), and Silvue (coatings).
Key Financial Metrics
| Metric (in thousands) | Six Months Ended June 30, 2006 |
|---|---|
| Net Sales | $94,683 |
| Gross Profit | $23,806 |
| Operating Income | $5,037 |
| Net Income | $2,112 |
| Net Income Per Share (Basic/Diluted) | $0.43 |
| Cash and Cash Equivalents (End of Period) | $16,113 |
| Net Cash Provided by Operating Activities | $8,609 |
| Long-Term Debt Outstanding | $50,000 |
| Total Assets | $458,427 |
Note: Gross margin for the period was approximately 25.1%.
Material Changes and Segment Performance
Due to the May 16, 2006 acquisition date, consolidated results are not comparable to the prior year. However, historical stand-alone data for the acquired businesses shows significant growth:
- CBS Personnel: Revenues increased $2.1 million (Q2) and $3.0 million (6-month) year-over-year, driven by light industrial and clerical staffing. Operating income rose to $4.9 million (Q2) and $8.0 million (6-month).
- Crosman: Net sales surged $6.1 million (Q2) and $17.0 million (6-month) year-over-year, primarily due to "soft air" product growth. Operating income increased to $4.5 million (Q2) and $8.5 million (6-month).
- Advanced Circuits: Net sales increased $1.6 million (Q2) and $3.2 million (6-month). Operating income remained relatively flat at $4.0 million (Q2) due to non-cash loan forgiveness charges and amortization.
- Silvue: Net sales increased $1.1 million (Q2) and $2.9 million (6-month), aided by the full inclusion of Nippon ARC operations. Operating income rose to $1.5 million (Q2) and $2.3 million (6-month).
Guidance, Outlook, and Risks
Outlook and Distributions: Management expects to pay quarterly distributions of $0.2625 per share beginning with the quarter ended September 30, 2006. A distribution of $0.1327 per share was paid on July 18, 2006, for the quarter ended June 30, 2006. The company estimates Cash Flow Available for Distribution (CAD) of $6.0 million for the six-month period.
Recent Acquisitions: On July 31, 2006 (subsequent to the reporting period), the company acquired Anodyne Medical Device, Inc. for approximately $30.4 million (cash and stock), expanding into medical support surfaces.
Risks and Contingencies:
- Debt Covenants: The company has a $225 million credit facility with covenants requiring a maximum debt-to-cash flow ratio of 3:1. The company was in compliance as of June 30, 2006.
- Customer Concentration: One customer accounted for 38% of Crosman's sales and 43% of its accounts receivable during the reporting period.
- Integration Risks: Risks associated with integrating the initial businesses and the subsequent Anodyne acquisition.
- Regulatory: Anodyne products are subject to FDA regulation; a subsidiary previously received a warning letter regarding design controls.
Investor Verification Checklist
- Acquisition Timing: Verify that consolidated revenue and profit figures only reflect 46 days of operations (May 16–June 30) and are not indicative of full-year performance.
- Debt Structure: Confirm the terms of the $225 million credit facility, specifically the $50 million term loan drawn and the $115 million delayed draw term loan availability.
- Non-GAAP Measures: Review the reconciliation of "Cash Flow Available for Distribution" (CAD) to GAAP net income to understand the basis for dividend projections.
- Subsequent Events: Assess the financial impact and integration risks of the July 31, 2006 acquisition of Anodyne Medical Device, Inc.
- Customer Concentration: Monitor the creditworthiness of Crosman's largest customer, which represents a significant portion of receivables.